Andhra Pradesh, India

Chintakunta Vamsee Krishna

This inventor holds 1 USPTO granted patent. Top assignee: Reddy US Therapeutics, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chintakunta Vamsee Krishna. Retrieved from https://idiyas.com/inventor/chintakunta-vamsee-krishna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chintakunta Vamsee Krishna: Innovator in Heterocyclic Compounds

Introduction

Chintakunta Vamsee Krishna is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of chemistry, particularly in the development of new heterocyclic compounds.

Latest Patents

His most recent patent is titled "Pyridine compounds, process for their preparation and compositions containing them." This invention provides new substituted pyridines, along with methods and compositions for their preparation and use. The compounds are aimed at treating various diseases and conditions, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, and dyslipidemia, particularly those mediated by the low expression of Perlecan.

Career Highlights

Chintakunta Vamsee Krishna is currently associated with Reddy US Therapeutics, Inc., where he continues to innovate and contribute to the field of therapeutic compounds. His work is pivotal in advancing medical treatments through the development of new chemical entities.

Collaborations

He collaborates with esteemed colleagues, including Manojit Pal and Christopher W Alexander, to further enhance the research and development of therapeutic solutions.

Conclusion

Chintakunta Vamsee Krishna's work in the field of heterocyclic compounds exemplifies the impact of innovative research on medical science. His contributions are vital for the advancement of treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…